Oxford GlycoSciences Plc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford GlycoSciences Plc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (339)	2/18/2003 3:13:05 AM
From: nigel bates	of 469

I would like a better deal, however As an OGS shareholder, I agree - I did suggest the deal would need to be sweetened. Problem is that they don't have all that much room for manoevre if a chunky cash bid comes along. I wouldn't turn down a TLRK deal (in the unlikely event of it being offered) either. As a CAT shareholder, I wish I hadn't been otherwise occupied, or I would have switched into OGS yesterday morning... edit Among smaller cap stocks, Britain's Oxford GlycoSciences (LSE: OGS.L - news) looks set to jump after the Financial Times reported that three more bidders are looking at the biotech company, including cancer specialist Xenova and Switzerland's Actelion ...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next